BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 38733174)

  • 1. Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.
    Zhou Y; Chu L; Li S; Chu X; Ni J; Jiang S; Pang Y; Zheng D; Lu Y; Lan F; Cai X; Yang X; Zhu Z
    Cancer Immunol Immunother; 2024 Jun; 73(8):141. PubMed ID: 38832974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vismodegib Potentiates Marine Antimicrobial Peptide Tilapia Piscidin 4-Induced Cytotoxicity in Human Non-Small Cell Lung Cancer Cells.
    Yeh WC; Tu YC; Chien TC; Hsu PL; Lee CW; Wu SY; Pan BS; Yu HH; Su BC
    Probiotics Antimicrob Proteins; 2024 May; ():. PubMed ID: 38743208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and immunological characteristics of postoperative relapse in lymph node-positive esophageal squamous cell cancer.
    Pan HG; Fang HL; Zhu C; Li S; Yi H; Zhang X; Yin XY; Song YJ; Chen D; Yin CT
    Cancer Med; 2024 May; 13(9):e7228. PubMed ID: 38733174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions.
    Ji H; Hu C; Yang X; Liu Y; Ji G; Ge S; Wang X; Wang M
    Signal Transduct Target Ther; 2023 Sep; 8(1):367. PubMed ID: 37752146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy.
    Krug J; Rodrian G; Petter K; Yang H; Khoziainova S; Guo W; Bénard A; Merkel S; Gellert S; Maschauer S; Spermann M; Waldner M; Bailey P; Pilarsky C; Liebl A; Tripal P; Christoph J; Naschberger E; Croner R; Schellerer VS; Becker C; Hartmann A; Tüting T; Prante O; Grützmann R; Grivennikov SI; Stürzl M; Britzen-Laurent N
    Gastroenterology; 2023 Mar; 164(3):392-406.e5. PubMed ID: 36402190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE).
    Yan X; Duan H; Ni Y; Zhou Y; Wang X; Qi H; Gong L; Liu H; Tian F; Lu Q; Sun J; Yang E; Zhong D; Wang T; Huang L; Wang J; Chaoyang Wang ; Wang Y; Wan Z; Lei J; Zhao J; Jiang T
    Int J Surg; 2022 Jul; 103():106680. PubMed ID: 35595021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody.
    Sharma SK; Mack KN; Piersigilli A; Pourat J; Edwards KJ; Keinänen O; Jiao MS; Zhao H; White B; Brooks CL; de Stanchina E; Madiyalakan MR; Hollingsworth MA; Radhakrishnan P; Lewis JS; Zeglis BM
    Clin Cancer Res; 2022 Mar; 28(5):948-959. PubMed ID: 34907079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.
    Wu T; Hu E; Xu S; Chen M; Guo P; Dai Z; Feng T; Zhou L; Tang W; Zhan L; Fu X; Liu S; Bo X; Yu G
    Innovation (Camb); 2021 Aug; 2(3):100141. PubMed ID: 34557778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.
    Chen B; Zhang G; Lai J; Xiao W; Li X; Li C; Mok H; Li K; Wang Y; Cao L; Jia M; Ren C; Wen L; Wei G; Lin J; Li Y; Zhang Y; Chen X; Wu X; Zhang H; Li M; Liu J; Balch CM; Liao N
    EBioMedicine; 2021 Sep; 71():103542. PubMed ID: 34454403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence.
    Rumgay H; Arnold M; Laversanne M; Whiteman DC; Thrift AP; Wei W; Lemmens VEPP; Soerjomataram I
    Am J Gastroenterol; 2021 May; 116(5):1072-1076. PubMed ID: 33929382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic effect of perineural invasion in surgically treated esophageal squamous cell carcinoma.
    Kim HE; Park SY; Kim H; Kim DJ; Kim SI
    Thorac Cancer; 2021 May; 12(10):1605-1612. PubMed ID: 33811752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resection.
    Zhang Y; Gao J; Zheng A; Yang H; Li J; Wu S; Zhao J; Meng P; Zhou F
    Transl Oncol; 2021 Jun; 14(6):101066. PubMed ID: 33744728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.
    McGrail DJ; Pilié PG; Rashid NU; Voorwerk L; Slagter M; Kok M; Jonasch E; Khasraw M; Heimberger AB; Lim B; Ueno NT; Litton JK; Ferrarotto R; Chang JT; Moulder SL; Lin SY
    Ann Oncol; 2021 May; 32(5):661-672. PubMed ID: 33736924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasia.
    Giamougiannis P; Martin-Hirsch PL; Martin FL
    Carcinogenesis; 2021 Apr; 42(3):327-343. PubMed ID: 33608706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Significance of Pathologic Complete Lymph Node Regression After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.
    Hsu PK; Yeh YC; Chien LI; Huang CS; Hsu HS
    Ann Surg Oncol; 2021 Apr; 28(4):2048-2058. PubMed ID: 33216266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in treating oesophageal cancer.
    Harada K; Rogers JE; Iwatsuki M; Yamashita K; Baba H; Ajani JA
    F1000Res; 2020; 9():. PubMed ID: 33042518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes.
    Heimes AS; Härtner F; Almstedt K; Krajnak S; Lebrecht A; Battista MJ; Edlund K; Brenner W; Hasenburg A; Sahin U; Gehrmann M; Hengstler JG; Schmidt M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003293
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.